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Background: Evidence-based preventive services for early detection of cancer and other health conditions offer
profound health benefits, yet Americans receive only half of indicated services. Policy initiatives promote the adoption
of information technologies to engage patients in care. We developed a theory-driven interactive preventive health
record (IPHR) to engage patients in health promotion. The model defines five levels of functionality: (1) collecting
patient information, (2) integrating with electronic health records (EHRs), (3) translating information into lay language,
(4) providing individualized, guideline-based clinical recommendations, and (5) facilitating patient action. It is
hypothesized that personal health records (PHRs) with these higher levels of functionality will inform and activate
patients in ways that simpler PHRs cannot. However, realizing this vision requires both technological advances
and effective implementation based upon clinician and practice engagement.
Methods/design: We are starting a two-phase, mixed-method trial to evaluate whether the IPHR is scalable
across a large number of practices and how its uptake differs for minority and disadvantaged patients. In phase 1,
40 practices from three practice-based research networks will be randomized to add IPHR functionality to their
PHR versus continue to use their existing PHR. Throughout the study, we will engage intervention practices to
locally tailor IPHR content and learn how to integrate new functions into their practice workflow. In phase 2, the
IPHR to all nonintervention practices to observe whether the IPHR can be implemented more broadly (Scalability).
Phase 1 will feature an implementation assessment in intervention practices, based on the RE-AIM model, to
measure Reach (creation of IPHR accounts by patients), Adoption (practice decision to use the IPHR), Implementation
(consistency, fidelity, barriers, and facilitators of use), and Maintenance (sustained use). The incremental effect of the
IPHR on receipt of cancer screening tests and shared decision-making compared to traditional PHRs will assess
Effectiveness. In phase 2, we will assess similar outcomes as phase 1 except for effectiveness.
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Discussion: This study will yield information about the effectiveness of new health information technologies designed
to actively engage patients in their care as well as information about how to effectively implement and disseminate
PHRs by engaging clinicians.
Trial registration: ClinicalTrials.gov: NCT02138448
Keywords: Health promotion, Information management, Informatics, Primary health care, Patient-centered careBackground
Evidence-based preventive services for the early detec-
tion of cancer and other health conditions offer pro-
found health benefits, yet Americans receive only half of
indicated services [1]. Colorectal, breast, cervical, and
prostate cancers are the leading causes of U.S. cancer
deaths, claiming 127,860 lives annually [2-4]. Though
many forms of cancer screening can reduce mortality, a
sizable proportion of the eligible population does not re-
ceive recommended screening tests. Only 54% of adults
are up-to-date with colorectal cancer screening, 74%
with breast cancer screening, and 80% with cervical can-
cer screening [5]. Less than half of adults are up-to-date
with clinical preventive services generally [1,6], and the
gap is even more pronounced among low-income Amer-
icans and racial and ethnic minorities [7]. A variety of
barriers affect patients, clinicians, and health-care sys-
tems [8-10]. Patients may be unaware that they need
screening, lack motivation to be tested, or face logistical
challenges. Clinicians may not promote needed tests due
to oversight, lack of time, and/or competing demands
[11]. The health system is fragmented and often lacks re-
sources, financing, and support to close these gaps. Cancer
screening has the added challenge of requiring shared
decision-making [12-14] and individualized risk assessment
[15] to determine at what age to start or stop screening,
how often to rescreen, which test to use (e.g., colonoscopy
versus stool blood test), or whether to screen at all
(e.g., PSA testing) [16]. Confusion is compounded by in-
consistencies among guidelines [16-20], weak evidence
supporting some screening tests [21,22], and public over-
enthusiasm for screening [23].
Some of these problems might be alleviated by health
information technology [24], especially personal health
records (PHRs). Some PHRs can offer patients direct ac-
cess to their electronic health record (EHR) [25,26],
which is empowering, speeds access to past screening
dates and results, and enables patients to discover po-
tential inaccuracies in their record. The next generation
of PHRs could offer even higher functionality [27]—they
could be programmed to apply evidence-based guide-
lines to assess prevention needs and to incorporate per-
sonal data to shape individualized recommendations.
The modern information age can enable patients to link
prevention guidelines with evidence-based educationalresources and decision aids, community services, logis-
tical details, and reminders. Automation has the poten-
tial to ease the information burden on clinicians and
empower patients with better information. Additionally,
while early EHR adopters documented that because of
the digital divide, at-risk populations less frequently used
PHRs [28], the digital divide has been steadily closing—
particularly for mobile applications [29]. Many leading
disparities experts now embrace technology as having
potential to reduce disparities in care [30].
There is, however, a shortage of objective evidence
that PHRs can achieve these lofty aims. A minority of
patients have a PHR [31], and most PHRs lack the en-
hanced functionality described above. The PHRs that
connect patients with their medical record often fail to
explain content in lay language. Some PHRs offer cancer
screening recommendations but rely on simple age- and
gender-based logic, ignoring other risk factors. There is
little empirical evidence about adoption of highly func-
tional PHRs in typical clinical settings, whether a range
of patients will use such systems, what functions patients
will use, and how use will be incorporated into practice
workflow and patient care.
Improving functionality of patient health records
We propose an innovative solution to the above prob-
lems based on a conceptual model that defined five
levels of functionality to make information technology
patient-centered [27]. These levels include: (1) collecting
patient reported information, (2) collecting existing clin-
ical information from EHRs, (3) translating medical in-
formation into lay language, (4) providing individualized
recommendations by applying information to evidence-
based guidelines, and (5) facilitating informed patient ac-
tion through embedded information resources and tools.
We created an innovative application that can be added
to existing PHRs, known as an Interactive Preventive
Health Record (IPHR), which features these five levels of
functionality and is currently integrated into several
major EHRs and PHRs (see www.MyPreventiveCare.org)
[27,32-34].
In brief, the IPHR addresses 18 clinical preventive ser-
vices, including screening tests, counseling services, pre-
ventive medications, and immunizations recommended
by the U.S. Preventive Services Task Force (USPSTF)
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practice’s PHR, through a single sign-on integration that
links the IPHR to the patient’s EHR record—essentially,
the IPHR will function as a seamless application within
the existing practice PHR. The IPHR extracts hundreds
of clinical data elements to individualize preventive rec-
ommendations. Patients also complete a health risk as-
sessment to provide information not available in the
EHR but necessary for making preventive service recom-
mendations. Based on this information and the USPSTF
guidelines, the IPHR applies programmed logic to gener-
ate a personally tailored list of recommendations. The
interface offers patients’ hyperlinks to detailed personal
messages that explain the preventive service and its ra-
tionale; relates relevant details in the patient’s history
(e.g., prior laboratory test values and dates) to the per-
sonalized recommendations; incorporates motivational
interviewing content; includes links to evidence-based
educational material, decision aids, and local resources
based on each patient’s profile; and summarizes the next
steps. Message content is modeled after the U.S. Department
of Health and Human Services www.Healthfinder.gov
and incorporates feedback from patient usability tests,
clinician focus groups, and longitudinal patient and
clinician advisory boards where stakeholders function as
co-investigators to help create and update content [36].
Content can be further tailored to meet individual user’s
needs (e.g., low health literacy content, large print, audio,
culturally appropriate images, local resources, free or sub-
sidized services, visual displays for mobile devices). After
patients use the IPHR, the system automatically forwards
a summary to the EHR inbox of the patient’s clinician for
appropriate follow-up.
Currently, most commercial PHRs can deliver only the
levels 1 and 2 functions (see Table 1) described in our
model and sometimes, elements of level 4 (basic age-
and gender-based recommendations). However, prior re-
search suggests that the other functions—translating
content into lay language (level 3), robust personalized
recommendations (level 4), and facilitating informedTable 1 Model for functionalities of a Patient-Centered Health
Functionalities
Level 1 Functionality: patient reported
information
Collect information, such as self-re
reported outcomes
Level 2 Functionality: existing clinical
information
Integrate patient reported informa
and/or claims data
Level 3 Functionality: interpretation of
information
Interpret information for the patie
information through a user-friend
Level 4 Functionality: individualization
of information
Provide individualized recommen
patient’s risk profile and on eviden
Level 5 Functionality: patient activation
and engagement
Facilitated informed patient action
vetted health information resourc
and logistical support for appoint
LEGEND. Adapted from Krist AH, Woolf SH. A vision for Patient-Centered Heath Infopatient action (level 5)—are essential to promote cancer
screening [37-48]. Successful implementation in the clin-
ical environment requires local tailoring, redesign of prac-
tice systems, and care coordination with the patient’s team
of caregivers (i.e., personal clinician, nurses, and support
staff ). As with any implementation strategy that requires
local tailoring, the scalability of implementing such a
system must be examined.
Preliminary studies
Three previous studies have evaluated the IPHR’s feasi-
bility. The first was a randomized controlled trial to test
whether mailing patients an invitation to use the IPHR
increased delivery of services (R18 HS17046-01, Efficacy
Trial, 2007–2010) [34]. Two prospective, observational
time-series analyses expanded IPHR implementation to
an entire primary care practice population in eight prac-
tices (R21 HS018811-01, Adoption Trial, 2010–2012)
and to six additional practices in Virginia (RFTO #17
290-07-100113, Implementation Trial, 2009–2011) [49].
These studies culminated in the production of a How-to
Guide for Using Patient-Centered Personal Health Re-
cords for Prevention, which is being disseminated nation-
ally by the Agency for Healthcare Research and Quality
(AHRQ) and which will inform this project’s implemen-
tation [50]. Our findings demonstrate that the IPHR is
technically feasible, increases delivery of preventive ser-
vices for patients enrolled in a controlled trial, and can
be fielded to an entire primary care population. However,
these tests occurred in a small group of Virginia practices
with a relatively homogenous patient population.
Through these studies, the IPHR was integrated into
three EHRs (EpicCare™, Enterprise™, and Professional™)
that represent 31% of the U.S. EHR market share [51].
The IPHR has also been integrated into two commercial
PHR platforms (MyChart™ and FollowMyHealth™). Cur-
rently, more than 70,000 patients and 190 clinicians are
using the IPHR. With this integration, practices success-
fully incorporated the IPHR into their workflow—using
it to prepare patients for visits, augment health behaviorInformation System
ported demographic and risk factor information as well as patient
tion with existing clinical information from electronic health records
nt by translating clinical findings into lay language and delivering health
ly interface
dations to the patient, such as screening reminders, based on the
ce-based guidelines
integrated with primary and specialty care through the provision of
es, decision aids, risk calculators, personalized motivational messages,
ments and follow-up
rmation Systems. JAMA 2011; 305(3):300-301.
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patient reminders for overdue services, prompt clinicians
about services patients need during encounters, and for-
mulate personalized prevention plans. However, consider-
able variation was documented, from 2% to 60%, in the
proportion of clinicians’ patients who used the IPHR.
Methods
This study is a two-phase, mixed-method trial designed to
assess implementation (phase 1) and scalability (phase 2)
with an embedded “real-world” comparative effectiveness
trial of a traditional PHR versus a PHR with added IPHR
functionality (see Figure 1 for the CONSORT study flow
diagram). Implementation will involve both technological
and practice-level adaptations, to be studied in three net-
works spanning eight states. Implementation targets are
based on Glasgow’s RE-AIM model [52-55]. Adoption,
Reach, Implementation, and Maintenance will assess im-
plementation and scalability, while, Effectiveness will as-
sess comparative effectiveness.
In preparation for phase 1, we will develop baseline as-
sessments, recruit and randomize practices, integrate the
IPHR into the EHRs and PHRs of study sites, assist with
practice training, and support local tailoring of IPHR
content. Phase 1 (Implementation and Comparative Ef-
fectiveness Trial) will include deployment of the IPHR
at 20 intervention practices and then contrasting the ef-
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Figure 1 Study CONSORT flow diagram.control practices in terms of delivery of recommended
screening test and promotion of shared decision-making.
Phase 2 (Scalability Assessment) will be assessed by
examining the three networks’ ability to extend the IPHR
to up to 130 nonintervention practices. At all phases,
the study will assess disparities in use and outcomes
among disadvantaged patients. For the purpose of this
study, disadvantaged patients are defined as minority
populations (e.g., African-Americans, Hispanics, and Native
Americans) and Medicaid beneficiaries (a surrogate for low
income). This study has been approved by the VCU In-
ternal Review Board (IRB HM15307) and contains no
more than minimal risk to participants. The risks are
limited to breaches of privacy and confidentiality.
Specific aims
Specific aim 1. To test the feasibility and scalability of
implementing the IPHR in three diverse practice-based
research networks with high proportions of minority
and underserved patients.
Phase 1 (Implementation Assessment). To measure four
implementation metrics in 20 randomly selected
practices (intervention sites from the comparative
effectiveness trial below):
– Sub-aim 1a. The percent of practices within
networks approached to participate in the study that
agree to and are able to use the IPHR (Adoption).ssessed for eligibility
Practices excluded 
- IPHR not available 
- Declined participation 
- Other randomized (n=40) 
Allocated to traditional PHR 
(n=20) 
- Assess receipt of PHR
 for SDM 
e) 
Follow-up (n=20) 
- Randomly select patients for 
SDM survey (n=100 per practice) 
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who make an office visit, use the IPHR, and receive
prevention recommendations during the first
(Reach) 6 months and subsequent 6 months
(practice-level Maintenance) after adoption.
– Sub-aim 1c. The percent of patients who continue
to use the IPHR 6 months after initial use (patient-
level Maintenance).
– Sub-aim 1d. The consistency, variation, and fidelity
of IPHR delivery across networks, practices,
clinicians, and staff; of practice workflow redesigns;
and of reported barriers and facilitators to use
(Implementation).
Phase 2—sub-aim 1e (Scalability Assessment). To
measure Adoption, Reach, Implementation, and
Maintenance of the IPHR when the above
implementation is replicated in up to 130 practices.
Specific aim 2 (Randomized Comparative Effectiveness
Trial, Phase 1). To compare, relative to traditional PHRs,
the incremental effectiveness of the additional IPHR fea-
tures. The trial will test two hypotheses in 20 interven-








Number of practices in
network
87 200
Number of practices eligible
for study
9 200
Electronic health record Cerner Epic






Female (%) 59 56
Ethnicity
Hispanic (%) 3 28
Race
African-American (%) 57 6
Asian (%) 1 13
White (%) 39 74
Native American (%) 0.1 1.6
Payer mix
Commercial (%) 62 15
Medicaid (%) 18 39
Medicare (%) 11 6
Self pay/indigent (%) 2 / 7 40use the IPHR will receive greater benefit than patients in
practices that use a traditional PHR, with even greater
benefits among IPHR users than traditional PHR users,
including:
– Increased delivery of indicated preventive services
(Hypothesis 1).
– Improved shared decision-making for cancer screen-
ing (Hypothesis 2).
Specific aim 3 (Disparities Assessment). To assess
whether IPHR use (Reach), preventive service delivery
rates (Effectiveness), and perceptions of the technology
differ for disadvantaged patients, defined as minorities
and Medicaid beneficiaries, in either phase 1 or phase 2.
Study sample
Practices are being recruited from three practice-based
research networks (PBRNs) that span multiple states
(Virginia Ambulatory Care Outcomes Research Net-
work—ACORN [56], OCHIN community health infor-
mation network—OCHIN [57-59], Research Involving
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sizes, cultures, and patients representing primary care;
(2) a large proportion of disadvantaged patients for testing
IPHR feasibility; (3) informatics infrastructure to support
IPHR integration; (4) recent introduction of PHRs as a
service to patients, providing an optimal window for com-
parative effectiveness evaluation; and (5) PBRN infras-
tructure that includes a multi-disciplinary research team,
practice liaisons with established practice relationships, ex-
pertise recruiting practices, and expertise with engaging
stakeholders and fielding research studies.
The ACORN network consists of more than 100 pri-
mary care practices reflecting the range of primary care
in Virginia [56]. The network includes practices from
seven health systems; using dozen of EHRs; located in
rural, suburban, and urban settings; and with a range of
practice organizational and ownership structures. For the
purposes of this study, we are focusing on nine practices
from the Virginia Commonwealth University Health Sys-
tem (VCUHS), allowing us to integrate the IPHR with one
EHR/PHR that is housed on one server. The VCUHS
practices are located in inner city Richmond and serve a
predominantly African-American population. RIOS Net is
a voluntary collaboration of clinicians serving southwest
New Mexico’s low-income, medically under-served, and
culturally diverse communities [60]. Members include 250
primary care clinicians from academic, Indian health,
community health, and private clinics. Similar to ACORN,
we will focus on recruiting 21 practices from the University
of New Mexico health system that utilize the same EHR/
PHR. The OCHIN is a nonprofit Health Center Controlled
Network headquartered in Portland Oregon [61]. It is a col-
laborative of over 70 primary health-care systems that oper-
ate more than 200 clinics across the United States. OCHIN
members are community health centers (CHCs), including
federally qualified health centers, rural sites, and school-
based health centers. All OCHIN practices will be eligible
for participation given that they use the same EHR/PHR
housed on a central server.Expert input 
- Evidence 






Figure 2 Engagement of stakeholders.Intervention and control conditions
Forty practices will be recruited to participate in phase
1, which will be conducted over the span of 1 year. Eli-
gible practices are those who have had an EHR for at
least 6 months, currently have a PHR, and agree to par-
ticipate. The decision to participate will be made by prac-
tices and, by extension, their clinicians. A representative
from each practice will provide consent to participate
through a memorandum of understanding. Randomization
will be done by the biostatistician and research coordinator
using a modified blocked design. To preserve allocation
concealment, practices will be matched into paired clusters
based on their associated health system, percent of Medic-
aid patients, and percent of practice PHR users and then
randomized into the intervention and control conditions
on a 1:1 ratio.
The intervention consists of the technical integration
of the IPHR into the EHR/PHR, modification of IPHR
content to support disadvantaged populations, practice
implementation of IPHR functions, and ongoing practice
adaptation to use the IPHR. A key element of this study
will be to engage intervention practice clinicians, pa-
tients, and experts as co-investigators throughout. Stake-
holder engagement is depicted in Figure 2. Engagement
activities will help to:
– Further inform and refine the study design;
– Advance and locally tailor IPHR content to better
meet users’ needs;
– Identify additional PHR functions needed to improve
care and decision-making;
– Integrate the IPHR into workflow;
– Interpret findings; and
– Disseminate results locally and nationally.
From a technical perspective, the IPHR will be pro-
grammed to integrate with each of the three networks’
EHR/PHR. This will include ensuring that all the re-






-MPC patient advisory board
-Usability testing
- MPC users (feedback)
Data Collection 
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creating links to the IPHR through the practice’s existing
PHR, transmitting IPHR clinician summaries and alerts
into the practice’s EHR, and locally tailoring IPHR con-
tent to meet each practice’s specific resources and needs.
Once technically integrated, all clinicians and staff at
intervention sites will be asked to encourage adult pa-
tients age 18–75 to use their PHR with its new IPHR
features. Three theories will be used to engage the study
practices and facilitate cultural and workflow changes
necessary to successfully adopt the new IPHR function-
ality. From Organizational Change Theory, study staff
will help practices to: (1) convey a sense of priority for
IPHR use, (2) form a guiding coalition, (3) develop and
communicate a shared vision, (4) empower practices to
act on their vision, (5) plan for short-term wins, and
(6) consolidate improvements and institutionalize suc-
cess [39,62-68]. Organizational Change Theory has been
successfully employed for implementing a range of prac-
tice changes as well as for adopting the use of health
information technology (HIT) [55,68-72]. In addition,
drawing from Complex Adaptive Systems Theory, study
staff will encourage practices to adopt a variety of solu-
tions, experimenting with and evolving their implemen-
tation strategy according to individual practice needs
[73]. Finally, using concepts consistent with Diffusion of
Innovations Theory, which identifies features that speed
adoption, study staff will locally tailor the IPHR in order
to ensure that the IPHR is advantageous to practices,
provides a better way to deliver prevention, improves
quality of care, improves information in the EHR, and is
easy to use [74,75].
To operationalize these theories, practices will be pro-
vided with benchmarking, feedback, practice facilitation,
online diaries, and learning collaboratives to set prior-
ities, share experiences, and institutionalize successes.
Specifically, three groups of practice champions will be
assembled, one in each network. Groups will consist of a
clinician, nurse, staff, or office manager from each inter-
vention site. Each group will participate in eight learning
collaboratives—four sessions in the 4 months prior to
adopting the IPHR and four in the year after. Learning
collaboratives will be led by the practice liaisons from
the PBRNs and follow an agenda successfully used in
two prior AHRQ studies [50]. Throughout the process,
study staff and champions will collaborate to determine
strategies to facilitate implementation. A second site
champion will also post biweekly diary entries via email
throughout the project. This will be another method to
engage stakeholders for input. The research team will
read entries in real time, provide feedback to the
champion, and discuss message content at research
meetings. This methodology was successfully used to
evaluate the implementation of 27 interventions inover 200 practices as part of a 5-year RWJF-funded
initiative [76,77].
Practices randomized to the control condition will de-
liver “usual” cancer screening and “usual” PHR function-
ality. The networks currently use commercial EHRs/
PHRs with levels 1, 2, and (partial) 4 functionality. Con-
trol practices will institute ordinary PHR updates. No
practices will be in a control condition in phase 2, which
follows completion of the randomized trial.
Data collection
Twelve data sources will be used to address the ques-
tions in our three specific aims: EHR data, IPHR data,
PHR data, practice records, network records, practice
surveys, champion surveys, learning collaborative obser-
vations and transcripts, practice recruitment assess-
ments, practice diaries, patient surveys, and patient
phone interviews.
EHR, IPHR, and PHR databases
The EHR, IPHR, and PHR databases will play a central
role in assessing all three aims. Every 6 months during
phase 1 and annually during phase 2, network IT staff
will transfer EHR data to the research database manager
for all patients age 18–75 who make an office visit.
Throughout the data transfer process, a standard data
transfer protocol will be used that allows us to link pa-
tients and their practices across all 12 data sources while
maximizing the patients’ privacy and confidentiality.
EHR data elements will include patient identification
number, age, gender, race-ethnicity, diagnostic codes,
family history, orders, screening test dates, and test re-
sults. IPHR/PHR data elements will include patient iden-
tification number and dates of use. The EHR database
will capture data for all patients, irrespective of whether
they establish an IPHR or PHR account, whereas the
IPHR and PHR databases will contain information only
about users.
Practice records, network notes, and recruitment
assessment
ACORN, OCHIN, and RIOS Net currently collect an-
nual inventories that include basic information about
clinicians—e.g., age, gender, degree, years in practice,
full-time equivalent—modeled after the Primary Care
Network Survey used by AHRQ [78]. Additionally, net-
work PIs and coordinators will complete an assessment
when approaching practices to participate in phases 1
and 2 of the study. This information will be used for in-
sights on IPHR adoption and implementation.
Practice survey
Practice surveys will be delivered electronically to all prac-
tice administrators, clinicians, and staff at intervention
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Implementation. Surveys will be collected at baseline and
1 year after adopting the IPHR. Questions will address
perceptions of preventive care and shared decision-making,
perceptions of health information technology, barriers and
facilitators to implementing the IPHR, consistency of IPHR
implementation, IPHR adaptation over time, and practice
culture. We will use questions from (a) the Information
Systems Expectations and Experiences (I-SEE) Survey to
assess elements of the Technology Acceptance Model
(TAM)—a validated pre- and post-implementation survey
associated with increased uptake of HIT; [79] (b) an assess-
ment of barriers for adopting HIT; [80] (c) the reciprocal
learning scale—an organizational culture characteristic
uniquely related to successful HIT implementation and
organizational change; [81] and the Patient-Centered Med-
ical Home Assessment (PCMH-A) that address practice
workflow [82].
Champion survey
A small group of clinicians, nurses, and support staff
(2–3 people) from intervention and control practices will
complete a baseline workflow and HIT infrastructure as-
sessment. Responses will be used as covariates in our
Implementation assessment and responses will be shared
with practice champions prior to adopting the IPHR to
help inform and guide implementation efforts. The
champion survey will include questions from the
PCMH-IT and specific questions about preventive care
delivery workflow [82].
Patient survey
To assess outcomes that cannot be determined from
EHR data, surveys will be mailed to 4,000 patients, 100
patients from each of the 40 phase 1 intervention and
control practices. A sample of 2,000 patients with office
visits in the first 6 months of the trial and 2,000 with of-
fice visits in the second 6 months of the trial will be ran-
domly selected to receive surveys. Because the purpose
of the study centers on cancer screening, the survey
sampling frame will be males age 50–75 and females age
40–75, stratified by age, gender, practice, and PHR use
(to include a minimum of 50% PHR users for the sub-
group analysis). The modified Dillman method will be
used to optimize the response rate for the mail survey
[83,84]. Surveys will be mailed on practice stationery and
in practice envelopes and include a $1 incentive [85].
As part of the comparative effectiveness evaluation
(outcome #2), surveys will assess components of shared
decision-making—knowledge, communication, decisional
conflict, and locus of control. Surveys will include a sepa-
rate set of questions for colorectal, breast, cervical, and
prostate cancer screening. National Cancer Institute’s
(NCI’s) Health Information National Trends Survey(HINTS) will assess knowledge gained by using the IPHR
[86]. Questions will address general knowledge about the
cancers, screening tests, screening recommendations, and
risks and benefits of screening. To assess whether the
IPHR helps patients weigh values regarding risks and be-
nefits, measures of both (a) process (patient-clinician
communication) and (b) patient perception (decisional
conflict) will be used. Questions from AHRQ’s Consumer
Assessment of HealthCare Providers and Systems (CAHPS)
survey will be used to measure communication. These
questions address the quality of the clinician-patient inter-
action as well as how often clinicians explained cancer
screening, listened carefully, provided understandable in-
structions, knew the patient’s medical history, and spent
enough time with the patient [87]. O’Connor’s low literacy
decisional conflict scale will be used to measure patient per-
spective on whether values were weighed [88-90]. Deci-
sional conflict assesses the patient’s uncertainty, how well
informed they feel, whether they have clarified their values,
and whether they feel supported. To assess whether the
IPHR fosters decision-making engagement at the de-
sired level, Degner’s locus of control metric will be used
to assess patients’ desired and actual level of involve-
ment in recent cancer screening decisions [91,92]. The
metric will ask patients to choose from one of five op-
tions on Degner’s continuum that best describes the rela-
tive role they or their clinicians played in making the
cancer screening decision.
Learning collaborative transcripts and observations
The main purpose of the learning collaboratives, which
will occur during the phase 1 implementation assess-
ment, will be to operationalize organizational change theory
and engage the practices in creating an IPHR implementa-
tion strategy. However, the learning collaboratives will also
serve as a rich source of qualitative information to under-
stand the practices’ implementation experience in real time.
In addition, learning collaboratives will serve as a setting to
engage the clinicians in the development IPHR content and
implementation strategies. Practices will identify 1–2 cham-
pions per site to participate in the learning collaboratives.
Accordingly, we will audio record all meetings, and the
study facilitator will take meeting notes to supplement
recordings.
Practice diaries
The online diaries will be used to see practice implemen-
tation through the lens of real-time participants. The
entries will identify changes to practice approaches and
IPHR content/use that could enhance adoption more
broadly. Practices will identify 1–2 diary keepers per site.
Diary keepers will be trained on how to use the online
diaries during locally based and virtual kickoff meetings in
year 1. Diary keepers will be asked to make entries
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IPHR tailoring, use and adaptation; general and IPHR-
specific information about patient engagement in prevent-
ive care; and issues related to sustained use of the practice
PHR and IPHR. Entries will be read in real time and dis-
cussed by the VCU project team. Regular responses will
be posted to facilitate rich diary interactions.Patient phone interviews
Interviews with patients will be conducted at the end of
phase 1 including 24 IPHR users, 15 who only use the
practice PHR, and 9 who do not use the IPHR or the
practice PHR. They will be stratified by insurance type
(Medicaid versus commercial) and race/ethnicity. The
interviews will focus on understanding what made pa-
tients use, and continue to use, the IPHR and practice
PHR; barriers for engaging online; and effectiveness and
perceived value of the IPHR and practice PHR.Table 3 Overview of data collection methods and analysis
Aim Data sources
Aim 1: Implementation: To field the
IPHR and evaluate use in terms of:
•IPHR/PHR database to measure w
the IPHR or PHR, and when and
use it
-Reach
•EHR database to measure the nu
IPHR users (denominator)-Adoption
-Implementation •Field notes to gather quantitative
insights on practice-level Adoptio
-Maintenance •Network records to measure prac
clinician characteristics (e.g., age)
•Learning collaborative transcripts,
practice diaries, and patient interv
IPHR implementation, including c
adaptation, and to qualitatively a
Effectiveness, and Maintenance
Scalability Data sources and analysis similar
learning collaborative transcripts,
Aim 2: To compare the Effectiveness of
the IPHR vs. traditional PHR functions
•EHR database to measure delive
recommended cancer screening
•IPHR/PHR database to identify us
•Patient survey of 4,000 randomly
to measure elements of shared d
•Learning collaborative transcripts,
practice diaries, and patient interv
perceptions
Aim 3: Disparities Assessment:
Difference in use, effect and perception
of technology for disadvantaged
populations
•EHR database to identify at risk p
and Medicaid beneficiaries) and
delivery of recommended cance
•IPHR/PHR database to stratify lev
minority and Medicaid status
•Patient interviews
Italicized words are data collection methods.
Bolded words are specific aim elements that will be assessed.Analytic plan
An overview of our data collection and methods is pre-
sented in Table 3. The outcomes for the implementation
and scalability assessment are framed around Glasgow’s
RE-AIM framework and will include Reach, Adoption,
Implementation, and Maintenance [52-55]. The com-
parative effectiveness trial will focus on Effectiveness.
All RE-AIM outcome elements will be defined by NCI’s
RE-AIM Construct Checklist, with the exception of ex-
penditures [93]. We plan a mixed-method study. The
denominator for our primary intention to treat analysis
of Reach, Effectiveness, and Maintenance will be all pa-
tients age 18–75 who are seen for an office visit during
the study period. Our access to EHR data in these prac-
tices allows us to assemble a complete denominator.
We also plan a user subgroup analysis to focus on pa-
tients in both arms who use the practice’s PHR (IQ
Health™ or MyChart™). Given that patients access the
IPHR through the practice’s PHR, this subgroup allowsAnalysis
hich patients use
how often they
•Percent of approached practices that agree to use
the IPHR (Adoption)
•Percent of patients age 18–75 with a visit who
create an IPHR account in months 1–12 (Reach)





•Percent of users who use the IPHR after 6 months
(patient-level Maintenance)
•Mixed methods analysis of (quantitative) practice
and clinician variation in Reach (two-level mixed-
effects logistic regression) and (qualitative)
consistency, variation, and fidelity of IPHR delivery
(immersion/crystallization analysis of transcripts and
diaries) (Implementation)





to phase 1 except phase 2 will not include collecting and analyzing
practice diaries, site visits, or patient interviews
ry of
tests
•Percent of patients up-to-date with all indicated
cancer screening for all practice patients (intention
to treat) and for PHR users (sub-group) (two-level
logistic regression)ers
•Shared decision-making outcomes (knowledge,
communication, decisional conflict, and decision




•Patient, practice, and clinician facilitators and







•Comparison of Reach and Effectiveness for the
disadvantaged versus general population (two-level
mixed-effects logistic regression)
•Patient interviews to understand technology
barriers and needs; technology impact; and unique
issues for disadvantaged patients
els of use by
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the IPHR. Additionally, this subgroup represents the
population most interested in using patient portals—a
key target audience for designing more advanced PHRs
for the growing number of patients who seek these
tools.
Whereas the ultimate benefit of the IPHR is to pro-
mote recommended preventive services, a secondary
benefit of potentially equal importance is to promote
shared decision-making. Showing patients their health
information, explaining content in lay language, present-
ing guideline disagreements, and providing decision aids
is intended to engage and activate patients to participate
in screening decisions. Accordingly, effectiveness out-
comes include both deliveries of preventive services and
elements of the decision-making process defined by
Sheridan et al. for the USPSTF (the patient [a] understands
the condition, [b] understands the service, [c] weighs
values regarding risks and benefits, and [d] is engaged in
decision-making at the desired level) [12]. Shared decision-
making outcomes to be measured will include patient
knowledge, clinician-patient communication, decisional
conflict, and difference in desired and actual desired locus
of decision-making control.
Our statistical calculations will account for up to three
sources of variation: variation within subjects measured
repeatedly over time, variation among the physicians
who see those patients, and variation among the prac-
tices where those physicians see their patients. Note that
the variability among physicians will be nested within
practices. Patient-level data will be collected for Reach,
Effectiveness, and Maintenance, while aggregate out-
comes will be used at the practice level. Multi-level,
mixed-effect models will be used to account for the
above variation in the evaluation of our aims. A similar ap-
proach will be used for Adoption and Implementation, al-
though the data collected will be practice-level information.
Specific aim 1
To test the feasibility and scalability of implementing the
IPHR in three diverse practice-based research networks
with high proportions of minority and underserved pa-
tients. The following strategies will be used for each sub-
aim.
1. Sub-aim 1a. The percent of practices that agree to
and are able to use the IPHR (Adoption). Because
strategies to field the IPHR will be practice wide,
involving a range of staff, Adoption is a practice-
level decision. We will use recruitment assessment
and network records to calculate descriptive statis-
tics about practices approached, practices willing to
use the IPHR, and practices that are able to use the
IPHR.2. Sub-aim 1b. The percent of patients who use the
IPHR in the first (Reach) and second and third years
(practice-level Maintenance) after adopting the
IPHR. We define Reach as the percent of patients
age 18–75 who make an office visit during the first
6 months after intervention sites adopt the IPHR
(denominator) and who (i) sign up for the IPHR,
(iii) complete the intake process, and (iii) receive
prevention recommendations (each as separate
numerators). IPHR data will provide the numerator,
and EHR data will provide the denominator.
Practice-level Maintenance applies the same defin-
ition for patients seen at intervention sites in months
6 through 24 after IPHR adoption.
3. Sub-aim 1c. The percent of patients who use the
IPHR more than 6 months after initial use. We
define patient-level Maintenance as the percent of
patients who establish an IPHR account
(denominator) and revisit the website at least once
6 months after initially establishing their IPHR
account (numerator).
4. Sub-aim 1d. The consistency, variation, and fidelity
of IPHR delivery across networks, practices,
clinicians, and staff (Implementation). While it is a
practice decision to adopt the IPHR, we expect
variation between practices and among clinicians in
how they promote and use the IPHR. Quantitatively,
we will compare Reach and Effectiveness at the
practice-level and clinician-level to quantify variation
in implementation at each level, using a two-level
mixed-effects logistic regression. From learning col-
laborative transcripts, practice diaries, and patient
interview transcripts, we will use a grounded theory
approach and immersion/crystallization techniques
to understand how different practices implemented
IPHR functions (both initially and over time) and
their consistency (versus adaptation) in implementa-
tion over time [94-100]. Specifically, we will engage
project participants in the learning process by shar-
ing emerging insights and having them share in the
interpretation of findings. We will use Atlas.ti soft-
ware to organize, code, and analyze data to identify
key findings and themes [101]. The analytic process
will include group participation in creating a code-
book based on (1) previous experience implement-
ing the IPHR, (2) input and advice from our
advisory panel, and (3) key factors that emerge
from the data through the immersion-
crystallization process of reading and rereading
the data, organizing the data around common
attributes, and developing an understanding of
themes implied by recurrent patterns. Preliminary
findings from this analysis will inform phase 2
implementation and scalability.
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Maintenance in the Scalability Assessment. As the
networks disseminate the IPHR across all practices
during phase 2, we will measure similar outcomes as
described in sub-aims 1a–d, although we will not
observe learning collaboratives or hold patient
interviews.
Specific aim 2
For the two effectiveness hypotheses detailed below, we
plan to (a) calculate overall outcomes and stratify out-
comes for each specific screening test and (b) compare
patients from intervention and control practices for both
the intention-to-treat population (all patients age 18–75
seen for a visit) and the user subgroup (all PHR users
age 18–75 seen for a visit) as described in the “Specific
aims” section. Linear mixed-effect (for numerical out-
comes) and generalized linear mixed-effect (for categor-
ical outcomes) models will be used to test the two
hypotheses listed below and will account for all three
levels of variation (within-subject, physician nested with
practice, and practice) using random effects.
1. Specific aim 2, hypothesis 1. Compare elements of
shared decision-making (knowledge, communication,
decisional conflict, and decision control) in
intervention versus control practices. Knowledge:
From the patient surveys, we will calculate the
percent of correct responses from the series of
knowledge questions. We will use a three-level
mixed-effects logistic regression for the intention-to-
treat and subgroup comparisons. Process of weighing
values (communication): Per the approach defined
by CAHPS, we will score the clinician-patient com-
munication questions on a 6-point scale and calcu-
late both the average scores and “top box” scores
(percent reporting the most positive responses) [87].
We will use a linear mixed-effect model for the 6-
point scale outcome and will use a generalized linear
mixed-effect model for the “top box” outcome, in
both the intention-to-treat and subgroup compari-
sons. Perception of weighing values (decisional con-
flict): Per protocol, we will score the overall
decisional conflict (score 0–100) and the four sub-
scores (uncertainty, informed, values, and support)
[91,92]. We will use mixed-effect multinomial lo-
gistic regression for the intention-to-treat and sub-
group comparisons. Engagement at the desired
level (locus of decision control): Using a mixed-
effect multinomial logistic regression, we will compare
the proportion of patients expressing differences in
preferred and actual locus of decision-making control
for intention-to-treat and subgroup comparisons
[91,92].2. Specific aim 2, hypothesis 2. Compare the percent of
patients who are up-to-date on all indicated cancer
screening tests at intervention and control practices.
Our primary Effectiveness outcome for which the
study is powered (see below) is the percent of
eligible patients who are up-to-date with all indi-
cated cancer screenings (all-or-none measure) [102].
Our prior studies demonstrated that the all-or-none
measure was the most sensitive to practice-level
changes. However, we also plan to measure the per-
cent of indicated cancer screenings that are up-to-
date (composite measure) and the percent of eligible
patients who are up-to-date with each individual
cancer screening test [102]. Eligibility for cancer
screening and “up-to-date” status will be based on
the USPSTF recommendations in effect at the time
of the office visit. Prostate cancer screening, breast
cancer screening age 40–50, and colorectal cancer
screening age 75–85 will be analyzed separately but
excluded from the composite and all-or-none mea-
sures. We will use a three-level mixed-effect logistic
regression for the all-or-none, composite, and indi-
vidual screening test comparisons.
Specific aim 3
Assess whether the use of the IPHR, benefits from the sys-
tem, and perception of the technology differ for disadvan-
taged patients. To determine whether exposure to the
IPHR affects disparities, we will compare the percentage
of minorities and Medicaid beneficiaries versus the gen-
eral population that use the IPHR (Reach) in both phase
1 (years 2–3) and phase 2 (years 4–5) using a three-level
mixed-effect logistic regression. Similarly, we will cal-
culate the difference in delivery of preventive services
(Effectiveness), using a three-level mixed-effect logistic
regression for the all-or-none, composite, and individual
screening tests. Both multi-level analyses will account
for practice-level and clinician-level variation. From qualita-
tive material, with an emphasis on the post-implementation
patient interviews, we will use a similar grounded the-
ory approach as described in specific aim 1d to un-
derstand disadvantaged patients’ perceptions of and
experience with the IPHR.
Sample size
Two power analyses were conducted for the primary (per-
cent of patients up-to-date with recommended cancer
screenings) and secondary effectiveness (shared decision-
making) outcomes of the study. Data from preliminary
studies were used to estimate the anticipated effect size
for each outcome. For the primary outcome, it was deter-
mined that 40 study sites (20 intervention and 20 control
practices) will provide 80% power, alpha = 0.05, to detect
an 8% (effect size 0.82) difference in being up-to-date with
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control groups in the intention to treat analysis and 80%
power, alpha = 0.05, to detect a 15% increase (effect size
0.82) in the subgroup analysis.
For the secondary outcome of the study, it was deter-
mined the 100 patients per study site, with stratified sam-
pling to ensure that at least 50% are IPHR users (for the
subgroup analysis), will provide 80% power, alpha = 0.05,
to detect a 10% knowledge score difference (effect size
0.75–0.80) between IPHR users and nonusers for the
intention-to-treat and subgroup analyses, respectively.
Study status
The overall study timeline is shown in Figure 3. Funded
in September 2013, the 40 study sites have been re-
cruited from the three PBRNs, practices have been ran-
domized to the intervention and control condition,
learning collaborative members and diary keepers have
been identified, the first learning collaborative and diary
entries have occurred, IPHR is in the process of being
updated, and the IPHR is being integrated into the three
participating systems’ existing EMR and PHR. We plan
to collect baseline data in September 2014, conduct
three more learning collaboratives between now and
February 2015, and launch the new IPHR functionality
15 February 2015.
Discussion
The second stage of EHR Meaningful Use will require








Development / Baseline Phase
Integrate IPHR into health system EHRs / PHRs
Tailor IPHR content to study sites
Program IPHR to work with mobile devices
Recruit, randomize, and assign practice sites
Conduct 4 learning collaboratives pre IPHR fielding
Phase 1 Implementation + Comparative Effectiveness Trial
Implement IPHR at intervention sites / observe use and outcomes
Practice diaries / practice + patient surveys
Conduct 4 learning collaboratives post IPHR fielding
Phase 2 Scalability Assessment
Offer IPHR to control sites and rest of health system
Oversee system implement IPHR
Data Collection and Analysis
Collect EMR / PHR / IPHR data
Track use of IPHR and traditional PHR
Conduct patient postal survey
Conduct practice clinician and champion survey
Conduct patient interviews
Figure 3 Study timeline.PHRs beginning in 2015. It remains to be seen whether
clinicians can accomplish this daunting task. It is also
unknown whether these efforts will pay off in terms of
improved care and health outcomes. We believe that
patient-centered PHRs with higher levels of functional-
ity, combined with practice redesign to make use of
these functions, can help patients obtain recommended
preventive care by linking them to their doctor’s records,
explaining information in lay language, displaying tai-
lored recommendations and educational resources, pro-
viding logistical support and tools to stimulate action,
and generating reminders. Appropriate delivery of these
evidence-based services should reduce the burdens of
chronic disease and prevent premature death.
This project will measure whether making these re-
sources available to primary care practices and patients
promotes shared decision-making and increases the de-
livery of recommended preventive services compared to
existing information systems. Specifically, it will yield
needed information about the effectiveness of new
health information technologies designed to more ac-
tively engage patients in their care as well as information
about how to most effectively implement and dissemin-
ate PHRs. If the integration of an IPHR into primary
care practice is proven effective and scalable, our study
findings will have wide ranging practice and policy
implications.
We incorporated several important design features to
ensure that this study has the potential for maximum
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PHR functionality versus embedding more personalized
IPHR content followed by a scalability assessment to de-
termine the feasibility and process of broadly integrating
IPHR functionality into a wide range of primary care prac-
tices. Second, our mixed-method design will provide a ro-
bust set of data to understand from multiple perspectives
the issues associated with engaging patients in PHR use.
This evaluation is proving timely given the recent Stage 2
Meaningful Use requirements. Third, because many of
our study practices serve a range of disadvantaged pop-
ulations, this study will allow us to examine disparities
in IPHR and PHR use and how potential disparities in
use of these HIT tools might influence outcomes in
care. Finally, a core element of our study design is to
engage key stakeholders throughout the research pro-
ject as co-investigators—clinicians, patients, and ex-
perts—using a variety of robust methods to ensure that
IPHR content meets users’ needs, implementation is
integrated into practice workflow, outcomes assessed
are meaningful for users, interpretation of findings is
guided by users’ experiences, and the voice of our users
is incorporated into dissemination activities. Through
collaboration with our stakeholders, we hope to ensure
our research directions address the prominent concerns
of primary care and patients.
Collectively, the above research study design features
strike a balance between the fidelity to our interventions
that is typically required for internal validity and the
need for quality improvement to embrace both individ-
ual variation and customization. This National Cancer
Institute-funded study is forging the way in striking a
balance between these tensions to ensure that our re-
search can be translated to clinical practice in a timely
manner.
We recognize that our study has several limitations.
While the goal is to improve the delivery of preventive
care for all patients, we expect that only a subset of pa-
tients will use the IPHR or even the practice’s PHR. We
expect that in the future, more and more patients will
seek health information online. For the purposes of this
study, we are assessing how practices increase their pa-
tient’s portal use (Reach). We will also engage patients
throughout IPHR refinement to ensure that content is
accessible, understandable, and meaningful as well as
create mobile ready content that can be accessed on a
smartphone. Another study challenge is the broad geo-
graphical distribution of our study practices. This makes
it more difficult to meaningfully engage local stake-
holders, ensure study protocols are carried out as de-
signed, and conduct observational assessments. We plan
to use several strategies to mitigate this limitation such
as standardizing study materials, using established PBRN
infrastructure, building on prior practice relationships,developing methods to promote virtual participation in
learning collaboratives (e.g., use of video meetings), and
sharing experiences between the three PBRNs.
PHRs hold great potential to improve patient educa-
tion, promote shared decision-making, facilitate more
in-depth conversations, and generally engage patients in
their care. However, more is needed from PHRs and
from the patients, clinicians, and practices using the
PHRs in order to achieve the desired outcomes. This
study will evaluate whether making PHRs more patient-
centered improves outcomes and it will generate needed
evidence about how to engage patients online in primary
care.Competing interests
The authors declare that they have no competing interests.Authors’ contribution
AK is the principle investigator for the project, led the project development,
and drafted the manuscript. RA facilitates the project coordination,
participated in the recruitment, fielding of the interventions, and drafted the
manuscript. RE participated in the project development, supervises the
qualitative data collection, and edited the manuscript. JD is the OCHIN site
principle investigator, participated in the project development, and edited
the manuscript. RS participated in the project development and is involved
in the data analysis. RW is the University of New Mexico-RIOS Net principle
investigator and edited the manuscript. KS is the project qualitative lead,
participated in fielding the interventions, and edited the manuscript. GI is
the University of New Mexico-RIOS Net informatics specialist who facilitates
integration and supported development of the study design. JP is the OCHIN
informatics specialist, facilitates the integration, and supported the development
of the study design. JD is the VCU informatics specialist, facilitates the integration,
and supported the development of the study design. PLK facilitates the project
coordination, participated in the recruitment, fielding of the interventions, and
edited the manuscript. JA is the OCHIN project coordinator, participated in the
recruitment, and fielding of the interventions. CR is one of the University of New
Mexico-RIOS Net project coordinator and edited the manuscript. MK is one of
the University of New Mexico-RIOS Net project coordinator. CN participated in
the recruitment of practices at OCHIN and development of the study design. DL
and SW participated in the project development. SHW participated in the project
development and helped write this manuscript. All authors read, edited, and
approved the final manuscript.Acknowledgements
Funding for this study is provided by the National Cancer Institute
(R01CA166375-01A1) and the National Center for Advancing Translational
Sciences (UL1TR000058). The opinions expressed in this manuscript are those
of the authors and do not necessarily reflect those of the funders.




1Department of Family Medicine and Population Health, Virginia
Commonwealth University, Richmond, VA, Virginia. 2OCHIN, Portland, OR,
Oregon. 3Department of Family Medicine, Oregon Health & Science
University, Portland, OR, Oregon. 4Department of Medical Informatics and
Clinical Epidemiology, Oregon Health & Science University, Portland, OR,
Oregon. 5Department of Biostatistics, Virginia Commonwealth University,
Richmond, VA, Virginia. 6Department of Family Medicine, University of New
Mexico, Albuquerque, NM, New Mexico. 7Department of Internal Medicine,
University of New Mexico, Albuquerque, NM, New Mexico. 8Department of
Internal Medicine, Virginia Commonwealth University, Richmond, VA, Virginia.
9Center on Society and Health, Virginia Commonwealth University,
Richmond, VA, Virginia.
Krist et al. Implementation Science 2014, 9:181 Page 14 of 16
http://www.implementationscience.com/content/9/1/181Received: 14 October 2014 Accepted: 24 November 2014References
1. McGlynn EA, Asch SM, Adams J, Keesey J, Hicks J, DeCristofaro A, Kerr EA:
The quality of health care delivered to adults in the United States. N Engl
J Med 2003, 348(26):2635–2645.
2. Jemal A, Siegel R, Xu J, Ward E: Cancer statistics, 2010. CA Cancer J Clin
2010, 60(5):277–300.
3. U.S. Cancer Statistics Working Group: United States Cancer Statistics:
1999–2007 incidence and mortality web-based report. 2010. http://www.
cdc.gov.uscs. Accessed Aug 2010.
4. Cancer topics. 2011. http://www.nci.nih.gov/cancertopics. Accessed Aug,
2011.
5. Behavioral Risk Factor Surveillance System: Prevalence data. 2010. http://
apps.nccd.cdc.gov/brfss/index.asp. Accessed Aug, 2011.
6. Bolen J, Adams M, Shenson D: Routine preventive services for older
women: a composite measure highlights gaps in delivery. J Womens
Health (Larchmt) 2007, 16(5):583–593.
7. U.S. Department of Health and Human Services: Healthy People 2010:
Understanding and Improving Health. 2nd edition. Washington, D.C:
Government Printing Office; 2000.
8. Kottke TE, Brekke ML, Solberg LI: Making “time” for preventive services.
Mayo Clin Proc Aug 1993, 68(8):785–791.
9. Jaen CR, Stange KC, Nutting PA: Competing demands of primary care: a
model for the delivery of clinical preventive services. J Fam Pract 1994,
38(2):166–171.
10. Woolf SH, Krist AH, Rothemich SF: Joining Hands: Partnerships Between
Physicians and the Community in the Delivery of Preventive Care. Washington
D.C.: Center for American Progress; 2006.
11. Yarnall KS, Pollak KI, Ostbye T, Krause KM, Michener JL: Primary care: is
there enough time for prevention? Am J Public Health 2003, 93(4):635–641.
12. Sheridan SL, Harris RP, Woolf SH: Shared decision making about screening
and chemoprevention. A suggested approach from the U.S. Preventive
Services Task Force. Am J Prev Med 2004, 26(1):56–66.
13. Braddock CH 3rd, Edwards KA, Hasenberg NM, Laidley TL, Levinson W:
Informed decision making in outpatient practice: time to get back to
basics. Jama 1999, 282(24):2313–2320.
14. Edwards A, Elwyn G: Evidence-based patient choice. Oxford, Great Britian:
Oxford University Press; 2001.
15. Breast cancer risk assessment tool. 2004. http://bcra.nci.nih.gov/brc/, 2004.
16. Prevention and care management. 2011. http://www.ahrq.gov/clinic/
prevenix.htm.
17. Smith RA, Cokkinides V, Brawley OW: Cancer screening in the United
States, 2009: a review of current American cancer society guidelines and
issues in cancer screening. CA Cancer J Clin 2009, 59(1):27–41.
18. Squiers LB, Holden DJ, Dolina SE, Kim AE, Bann CM, Renaud JM: The
public’s response to the U.S. Preventive Services Task Force’s 2009
recommendations on mammography screening. Am J Prev Med 2011,
40(5):497–504.
19. Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Dash C,
Giardiello FM, Glick S, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A,
Bond J, Johnson D, Johnson CD, Winawer SJ: Screening and surveillance
for the early detection of colorectal cancer and adenomatous polyps,
2008: a joint guideline from the American Cancer Society, the US
Multi-Society Task Force on Colorectal Cancer, and the American College
of Radiology. Gastroenterology 2008.
20. Levin B, Smith RA, Feldman GE, Colditz GA, Fletcher RH, Nadel M,
Rothenberger DA, Schroy PS 3rd, Vernon SW, Wender R: Promoting early
detection tests for colorectal carcinoma and adenomatous polyps: a
framework for action: the strategic plan of the National Colorectal
Cancer Roundtable. Cancer 2002, 95(8):1618–1628.
21. Petitti DB, Teutsch SM, Barton MB, Sawaya GF, Ockene JK, DeWitt T: Update
on the methods of the U.S. Preventive Services Task Force: insufficient
evidence. Ann Intern Med 2009, 150(3):199–205.
22. Guyatt GH, Helfand M, Kunz R: Comparing the USPSTF and GRADE
approaches to recommendations. Ann Intern Med 2009, 151(5):363. author
reply 363–364.
23. Schwartz LM, Woloshin S, Fowler FJ Jr, Welch HG: Enthusiasm for cancer
screening in the United States. JAMA 2004, 291(1):71–78.24. Taplin SH, Rollason D, Camp A, di Donato K, Maggenheimer E: Imagining
an electronic medical record for turning cancer screening knowledge
into practice. Am J Prev Med 38(1):89–97
25. Tang PC, Ash JS, Bates DW, Overhage JM, Sands DZ: Personal health
records: definitions, benefits, and strategies for overcoming barriers to
adoption. J Am Med Inform Assoc 2006, 13(2):121–126.
26. Tang PC, Lee TH: Your doctor’s office or the Internet? Two paths to
personal health records. N Engl J Med 2009, 360(13):1276–1278.
27. Krist AH, Woolf SH: A vision for patient-centered health information
systems. JAMA 2011, 305(3):300–301.
28. Chaudhry B, Wang J, Wu S, Maglione M, Mojica W, Roth E, Morton SC,
Shekelle PG: Systematic review: impact of health information technology
on quality, efficiency, and costs of medical care. Ann Intern Med 2006,
144(10):742–752.
29. Zickuhr K, Smith A: Digital differences. 2012. http://pewinternet.org/
Reports/2012/Digital-differences/Main-Report/The-power-of-mobile.aspx.
Accessed June, 2012.
30. Turner-Lee N, Smedley BD, Miller J: Minorities, mobile broadband and the
management of chronic diseases. Washington DC: Joint Center for Political
and Economic Studies; 2012.
31. Connecting for Health: Americans overwhelmingly believe electronic
personal health records could improve their health. 2008. http://www.
connectingforhealth.com/resources/ResearchBrief-200806.pdf. Accessed
May, 2009.
32. Krist AH, Peele E, Woolf SH, Rothemich SF, Loomis JF, Longo DR, Kuzel AJ:
Designing a patient-centered personal health record to promote
preventive care. BMC Med Inform Decis Mak 2011, 11:73.
33. Krist AH: Featured projects. Patients take a bite of prevention apple with
web-based interactive personal health records. 2011. http://healthit.ahrq.
gov/sites/default/files/docs/page/Krist_Success_Story_Final_7.29.2011.pdf.
Accessed Aug, 2011.
34. Krist AH, Woolf SH, Rothemich SF, Johnson RE, Peele E, Cunningham T,
Longo DR, Bello G, Matzke GR: Randomized trial of an interactive
preventive health record to enhance the delivery of recommended care.
Ann Fam Med 2012, 10(4):312–319.
35. Preventive services. 2010. http://www.ahrq.gov/clinic/uspstfix.htm.
Accessed July, 2010.
36. HealthFinder.gov. 2014. http://healthfinder.gov/. Accessed February, 2014.
37. Skinner CS, Campbell MK, Rimer BK, Curry S, Prochaska JO: How effective
is tailored print communication? Ann Behav Med Fall 1999,
21(4):290–298.
38. Rimer BK: Improving the use of cancer screening for older women.
Cancer 1993, 72(3 Suppl):1084–1087.
39. Glanz K, Lewis FM, Rimer B: Health Behavior and Health Education. 2nd
edition. San Francisco: Jossey-Bass; 1997.
40. Mullen PD, Simons-Morton DG, Ramirez G, Frankowski RF, Green LW, Mains
DA: A meta-analysis of trials evaluating patient education and counseling
for three groups of preventive health behaviors. Patient Educ Couns 1997,
32(3):157–173.
41. Solberg LI, Brekke ML, Fazio CJ, Fowles J, Jacobsen DN, Kottke TE, Mosser G,
O'Connor PJ, Ohnsorg KA, Rolnick SJ: Lessons from experienced guideline
implementers: attend to many factors and use multiple strategies. Jt
Comm J Qual Improv 2000, 26(4):171–188.
42. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for
patients with chronic illness. JAMA 2002, 288(14):1775–1779.
43. Bodenheimer T, Wagner EH, Grumbach K: Improving primary care for
patients with chronic illness: the chronic care model, part 2. JAMA 2002,
288(15):1909–1914.
44. Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A:
Improving chronic illness care: translating evidence into action. Health
Aff (Millwood) 2001, 20(6):64–78.
45. Glasgow RE, Orleans CT, Wagner EH: Does the chronic care model serve
also as a template for improving prevention? Milbank Q 2001,
79(4):579–612. iv-v.
46. Orleans CT, Schoenbach VJ, Wagner EH, Quade D, Salmon MA, Pearson DC,
Fiedler J, Porter CQ, Kaplan BH: Self-help quit smoking interventions:
effects of self-help materials, social support instructions, and telephone
counseling. J Consult Clin Psychol 1991, 59(3):439–448.
47. Street RL, Gold WR, Manning TE: Health promotion and interactive
technology: theoretical applications and future directions. London, England:
Lawrence Wrlbaum Associates; 1997.
Krist et al. Implementation Science 2014, 9:181 Page 15 of 16
http://www.implementationscience.com/content/9/1/18148. Glasgow RE, McKay HG, Boles SM, Vogt TM: Interactive computer
technology, behavioral science, and family practice. J Fam Pract 1999,
48(6):464–470.
49. Krist AH, Woolf SH, Bello G, Sabo RT, Longo DR, Kashiri P, Etz RS, Loomis J,
Rothemich SF, Peele JE, Cohn J: Engaging primary care patients to use a
patient-centered personal health record. Ann Fam Med 2014,
12:418–426.
50. Department of Family Medicine: Virginia Commonwealth University. A
How-To Guide for Using Patient-Centered Personal Health Records to
Promote Prevention. 2012. http://healthit.ahrq.gov/KRIST-IPHR-Guide-0612.
pdf. Accessed June, 2012.
51. American EHR Partners: Market share and top 10 rated ambulatory EHR
products by practice size. 2011. http://www.americanehr.com/blog/2011/
10/new-ehr-market-share-report-from-americanehr-available/. Accessed
June, 2012.
52. Reach Effectiveness Adoption Implementation Maintenance (RE-AIM).
2011. www.re-aim.org. Accessed Sept, 2011.
53. Glasgow RE, Klesges LM, Dzewaltowski DA, Estabrooks PA, Vogt TM:
Evaluating the impact of health promotion programs: using the RE-AIM
framework to form summary measures for decision making involving
complex issues. Health Educ Res 2006, 21(5):688–694.
54. Glasgow RE: RE-AIMing research for application: ways to improve
evidence for family medicine. J Am Board Fam Med 2006, 19(1):11–19.
55. Borkan JM: Mixed methods studies: a foundation for primary care
research. Ann Fam Med 2004, 2(1):4–6.
56. ACORN: Ambulatory Care Outcomes Research Network. http://www.
acorn.fap.vcu.edu/. Accessed Sept, 2014.
57. Devoe JE, Gold R, Spofford M, Chauvie S, Muench J, Turner A, Likumahuwa
S, Nelson C: Developing a network of community health centers with a
common electronic health record: description of the Safety Net West
Practice-based Research Network (SNW-PBRN). J Am Board Fam Med
2011, 24(5):597–604.
58. DeVoe JE, Likumahuwa S, Eiff MP, Nelson CA, Carroll JE, Hill CN, Gold R,
Kullberg PA: Lessons learned and challenges ahead: report from the
OCHIN Safety Net West practice-based research network (PBRN). J Am
Board Fam Med 2012, 25(5):560–564.
59. Devoe JE, Sears A: The OCHIN community information network: bringing
together community health centers, information technology, and data
to support a patient-centered medical village. J Am Board Fam Med 2013,
26(3):271–278.
60. Research Involving Outpatient Settings Network (RIOSnet). http://fcm.
unm.edu/programs/rios-net/index.html. Accessed Sept, 2014.
61. OCHIN. http://www.ochin.org/. Accessed Sept, 2014.
62. Glanz K, Rimer BK: Theory at a glance. A guide for health promotion
practice. 2005. 2nd:http://www.sbccimplementationkits.org/
demandrmnch//wp-content/uploads/2014/02/Theory-at-a-Glance-%E2%80%
93-A-Guide-For-Health-Promotion-Practice.pdf. Accessed May, 2009.
63. Porras JI, Robertson PJ: Organization development theory: a typology and
evaluation. In Research in Organizational Change and Development. Edited
by Woodman RW, Passmore WA. Greenwich, CN: JAI Press; 1987.
64. Fischer LR, Solberg LI, Kottke TE: Quality improvement in primary care
clinics. Jt Comm J Qual Improv 1998, 24(7):361–370.
65. Solberg LI: Improving medical practice: a conceptual framework. Ann
Fam Med 2007, 5(3):251–256.
66. Koeck C: Time for organisational development in healthcare organisations.
Improving quality for patients means changing the organisation. BMJ 1998,
317(7168):1267–1268.
67. Senge PM: The Fifth Discipline: The Art & Practice of the Learning Organization.
New York, NY: Currency Doubleday; 1990.
68. Kotter J: Winning at change. Leader to Leader, 10, 27–33. 1999. http://
leadertoleader.org/leaderbooks/L2L/fall98/kotter.html. Accessed May, 2009.
69. Feifer C, Ornstein SM, Jenkins RG, Wessell A, Corley ST, Nemeth LS,
Roylance L, Nietert PJ, Liszka H: The logic behind a multimethod
intervention to improve adherence to clinical practice guidelines in
a nationwide network of primary care practices. Eval Health Prof 2006,
29(1):65–88.
70. Ovretveit J, Scott T, Rundall TG, Shortell SM, Brommels M: Implementation
of electronic medical records in hospitals: two case studies. Health Policy
2007, 84(2–3):181–190.
71. Creswell JW, Fetters MD, Ivankova NV: Designing a mixed methods study
in primary care. Ann Fam Med 2004, 2(1):7–12.72. Scott JT, Rundall TG, Vogt TM, Hsu J: Kaiser Permanente’s experience of
implementing an electronic medical record: a qualitative study. BMJ
2005, 331(7528):1313–1316.
73. Plesk P: Redesigning health care with insights from the science of
complex adaptive systems. In Crossing the Quality Chasm: A New Health
System for the 21st Century. Edited by Io M. Washington, DC: National
Academy Press; 2001:322–335.
74. Rogers EM: Diffusion of Innovations. 5th edition. New York, NY: Free Press;
2003.
75. Sussman S, Valente TW, Rohrbach LA, Skara S, Pentz MA: Translation in the
health professions: converting science into action. Eval Health Prof 2006,
29(1):7–32.
76. Etz RS, Cohen DJ, Woolf SH, Holtrop JS, Donahue KE, Isaacson NF, Stange
KC, Ferrer RL, Olson AL: Bridging primary care practices and communities
to promote healthy behaviors. Am J Prev Med 2008, 35(5 Suppl):S390–397.
77. Cohen DJ, Leviton LC, Isaacson N, Tallia AF, Crabtree BF: Online diaries
for qualitative evaluation: gaining real-time insights. Am J Eval 2006,
27:163–184.
78. Tierney WM, Oppenheimer CC, Hudson BL, Benz J, Finn A, Hickner JM,
Lanier D, Gaylin DS: A national survey of primary care practice-based
research networks. Ann Fam Med 2007, 5(3):242–250.
79. Wakefield DS, Halbesleben JR, Ward MM, Qiu Q, Brokel J, Crandall D:
Development of a measure of clinical information systems expectations
and experiences. Med Care 2007, 45(9):884–890.
80. Ajami S, Bagheri-Tadi T: Barriers for Adopting Electronic Health Records
(EHRs) by Physicians. Acta informatica medica: AIM: J Soc Med Informatics of
Bosnia & Herzegovina: casopis Drustva za medicinsku informatiku BiH 2013,
21(2):129–134.
81. Leykum LK, Palmer R, Lanham H, Jordan M, McDaniel RR, Noel PH, Parchman
M: Reciprocal learning and chronic care model implementation in primary
care: results from a new scale of learning in primary care. BMC Health Serv
Res 2011, 11:44.
82. Patient centered medical home assessment (PCMH-A). http://www.
improvingchroniccare.org/downloads/pcmha.pdf. Accessed Sept, 2014.
83. Dillman D: Mail and Internet Surveys: The Total Design Method. 2nd edition.
Hoboken NJ: John Wiley and Sons; 1999.
84. Dillman DA: Mail and Internet Surveys: The Tailored Design Method. 2nd
edition. Hoboken NJ: John Wiley Company; 1999.
85. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I:
Increasing response rates to postal questionnaires: systematic review.
BMJ 2002, 324(7347):1183.
86. Health Information National Trends Survey. 2007. http://hints.cancer.gov/
questions.aspx. Accessed Sept, 2011.
87. CAHPS Clinician & Group Survey. 2011. https://cahps.ahrq.gov/Surveys-
Guidance/CG/index.html. Accessed Sept, 2011.
88. O'Connor AM: Validation of a decisional conflict scale. Med Decis Making
1995, 15(1):25–30.
89. O'Connor A: Decisional Conflict Scale. 4th edition. Ottawa: University of
Ottawa; 1999.
90. Linder SK, Swank PR, Vernon SW, Mullen PD, Morgan RO, Volk RJ: Validity of
a low literacy version of the Decisional Conflict Scale. Patient Educ Couns.
91. Degner LF, Sloan JA: Decision making during serious illness: what role do
patients really want to play? J Clin Epidemiol 1992, 45(9):941–950.
92. Degner LF, Sloan JA, Venkatesh P: The control preferences scale. Can J
Nurs Res Fall 1997, 29(3):21–43.
93. Measuring the use of the RE-AIM framework constructs checklist. 2011.
http://www.re-aim.hnfe.vt.edu/resources_and_tools/measures/
checklistdimensions.pdf. Accessed Sept, 2011.
94. Krueger RA: Focus group: a practical guide for applied research. 3rd edition.
Thousand Oaks, CA: Sage Publications; 2000.
95. Krueger RA: Analyzing and Reporting Focus Groups Results, (Focus Group Kit,
Vol #6). Thousand Oaks, CA: Sage Publications; 1997.
96. Patton MQ: Qualitative Research and Evaluation Methods. Thousand Oaks,
CA: Sage Publications; 2001.
97. Miles MB, Huberman M: Qualitative Data Analysis: An Expanded Sourcebook.
2nd edition. Newbury Park, CA: Sage Publications; 1994.
98. Devers KJ: How will we know “good” qualitative research when we see
it? Beginning the dialogue in health services research. Health Serv Res
1999, 34(5 Pt 2):1153–1188.
99. Richards L, Morse JM: README FIRST for a User's Guide to Qualitative
Methods. 2nd edition. Thousand Oaks, CA: SAGE Publications, Inc; 2007.
Krist et al. Implementation Science 2014, 9:181 Page 16 of 16
http://www.implementationscience.com/content/9/1/181100. Crabtree BF, Miller WL: Doing Qualitative Research. 2nd edition. California:
Sage Oaks; 1999.
101. Ryan GW, Bernard HR: Techniques to identify themes. Field Methods 2003,
15:85–109.
102. Nolan T, Berwick DM: All-or-none measurement raises the bar on
performance. JAMA 2006, 295(10):1168–1170.
doi:10.1186/s13012-014-0181-1
Cite this article as: Krist et al.: MyPreventiveCare: implementation and
dissemination of an interactive preventive health record in three
practice-based research networks serving disadvantaged patients—a
randomized cluster trial. Implementation Science 2014 9:181.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
